Filter News
Area of Research
- Biological Systems (1)
- Biology and Environment (32)
- Clean Energy (27)
- Climate and Environmental Systems (1)
- Computational Biology (2)
- Computational Engineering (1)
- Electricity and Smart Grid (1)
- Fuel Cycle Science and Technology (1)
- Functional Materials for Energy (1)
- Fusion and Fission (2)
- Fusion Energy (1)
- Isotopes (7)
- Materials (29)
- Materials for Computing (8)
- National Security (36)
- Neutron Science (14)
- Nuclear Science and Technology (2)
- Supercomputing (54)
News Topics
- (-) Biomedical (61)
- (-) Frontier (45)
- (-) Mercury (12)
- (-) National Security (72)
- (-) Net Zero (14)
- (-) Polymers (33)
- 3-D Printing/Advanced Manufacturing (128)
- Advanced Reactors (34)
- Artificial Intelligence (100)
- Big Data (60)
- Bioenergy (92)
- Biology (101)
- Biotechnology (24)
- Buildings (65)
- Chemical Sciences (73)
- Clean Water (31)
- Climate Change (105)
- Composites (30)
- Computer Science (198)
- Coronavirus (46)
- Critical Materials (29)
- Cybersecurity (35)
- Decarbonization (85)
- Education (4)
- Element Discovery (1)
- Emergency (2)
- Energy Storage (112)
- Environment (200)
- Exascale Computing (42)
- Fossil Energy (6)
- Fusion (58)
- Grid (66)
- High-Performance Computing (93)
- Hydropower (11)
- Irradiation (3)
- Isotopes (57)
- ITER (7)
- Machine Learning (50)
- Materials (147)
- Materials Science (146)
- Mathematics (9)
- Microelectronics (4)
- Microscopy (51)
- Molten Salt (9)
- Nanotechnology (60)
- Neutron Science (137)
- Nuclear Energy (111)
- Partnerships (51)
- Physics (64)
- Quantum Computing (37)
- Quantum Science (72)
- Renewable Energy (2)
- Security (25)
- Simulation (51)
- Software (1)
- Space Exploration (25)
- Statistics (3)
- Summit (59)
- Sustainable Energy (130)
- Transformational Challenge Reactor (7)
- Transportation (98)
Media Contacts
As the second-leading cause of death in the United States, cancer is a public health crisis that afflicts nearly one in two people during their lifetime.
Oak Ridge National Laboratory will partner with Cincinnati Children’s Hospital Medical Center to explore ways to deploy expertise in health data science that could more quickly identify patients’ mental health risk factors and aid in
The prospect of simulating a fusion plasma is a step closer to reality thanks to a new computational tool developed by scientists in fusion physics, computer science and mathematics at ORNL.
A select group gathered on the morning of Dec. 20 at the Department of Energy’s Oak Ridge National Laboratory for a symposium in honor of Liane B. Russell, the renowned ORNL mammalian geneticist who died in July.
Gina Tourassi has been appointed as director of the National Center for Computational Sciences, a division of the Computing and Computational Sciences Directorate at Oak Ridge National Laboratory.
A team of researchers at Oak Ridge National Laboratory have demonstrated that designed synthetic polymers can serve as a high-performance binding material for next-generation lithium-ion batteries.
Sometimes solutions to the biggest problems can be found in the smallest details. The work of biochemist Alex Johs at Oak Ridge National Laboratory bears this out, as he focuses on understanding protein structures and molecular interactions to resolve complex global problems like the spread of mercury pollution in waterways and the food supply.
OAK RIDGE, Tenn., May 7, 2019—The U.S. Department of Energy today announced a contract with Cray Inc. to build the Frontier supercomputer at Oak Ridge National Laboratory, which is anticipated to debut in 2021 as the world’s most powerful computer with a performance of greater than 1.5 exaflops.
Using artificial neural networks designed to emulate the inner workings of the human brain, deep-learning algorithms deftly peruse and analyze large quantities of data. Applying this technique to science problems can help unearth historically elusive solutions.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.